Pro 2014-025 (Announcement on Resolution of 13th Supervisory Committee of Jianfeng Group's 7th Session)
Release time:
2020-08-05
Stock Code: 600668 Stock Abbreviation: Jianfeng Group No.: Pro 2014-025
Bond Abbreviation: 13 Jianfeng 01 Bond Code: 122227
Zhejiang Jianfeng Group Co., Ltd.
7th 13th Board of Supervisors Resolution Announcement
The board of directors and all directors of the company guarantee this announcement The content does not contain any false records, misleading statements or major omissions, and bears individual and joint responsibility for the authenticity, accuracy and completeness of its content .
On October 27, 2014, Zhejiang Jianfeng Group Co., Ltd. held the 13th meeting of the 7th Board of Supervisors by means of communication. The company currently has 5 supervisors and 5 supervisors who participated in the voting. It complies with the relevant provisions of the "Company Law" and the company's "Articles of Association", and the resolutions made are legal and valid. The following resolutions were passed at the voting meeting:
1. the company's 2014 third quarter report
The board of supervisors believes that:(1) the preparation and review procedures of the 2014 third quarter report comply with laws, regulations, the company's "Articles of Association" and the company's internal management system Various provisions;(2) The content and format of the 2014 third quarter report comply with the regulations of the China Securities Regulatory Commission and the Shanghai Stock Exchange, the information contained can truly reflect the company's operation, management and financial status in the third quarter of 2014 from all aspects;(3) The board of supervisors did not find that the personnel involved in the preparation and review of the "2014 Third Quarter Report" violated confidentiality regulations. behavior.
After deliberation and voting, passed the bill with 5 votes in favor, 0 votes against and 0 abstentions.
2. "Proposal on Changes in Company Accounting Policies"
The Board of Supervisors believes that this adjustment is a reasonable change and adjustment in accordance with the relevant accounting standards newly promulgated or revised by the Ministry of Finance in 2014, and the implementation of the relevant accounting standards newly promulgated or revised by the Ministry of Finance in 2014 can more objectively and fairly reflect the company's financial status and operating results; the relevant decision-making procedures are in compliance with relevant laws and regulations and the Company's Articles of Association, and there is no harm to the interests of the Company and its shareholders. The Supervisory Board agreed to change the Company's accounting policies in accordance with the relevant accounting standards newly issued or revised by the Ministry of Finance in 2014.
After deliberation and voting, the bill was passed by 5 votes in favor, 0 votes against, and 0 abstentions.
3. Proposal
on the expiration of the term of office of the board of supervisors According to the company's "Articles of Association", the term of office of the board of supervisors is three years, and the term of office of the current board of supervisors will need to be renewed. The company's largest shareholder, Jinhua Tongji State-owned Assets Investment Company, recommended Mr. Li Ziqiang and Mr. Ouyang Shaojian as candidates for the company's eighth board of supervisors; the current board of supervisors recommended Mr. Yuan Jie as a candidate for the company's eighth board of supervisors, the above three candidates Will be submitted to the general meeting of shareholders for election.
After deliberation and voting, the bill was passed by 5 votes in favor, 0 votes against, and 0 abstentions.
hereby announces
Zhejiang Jianfeng Group Co., Ltd. Supervisory Board
October 27, 2014
Attached: Resume of Supervisor Candidate
Li Ziqiang: Born in October 1962, Bachelor Degree, Senior Economist. He joined the work in August 1983 and served as Deputy Chief of the General Section and Chief of the Secretary Section of the Jinhua Municipal Party Committee Office. Joined the company in 1993 and successively served as the company's public relations manager, general manager's office director, general manager assistant, general manager of Jianfeng Cable, general manager of Zhejiang Jinfa Co., Ltd., and deputy general manager of the company. He is currently the Chairman of the Supervisory Board of the Company.
Ouyang Shaojian: born in December 1976, undergraduate, economist. He joined the work in August 1996 and served as a teacher at Zuo Kou Primary School in Chun 'an, Zhejiang, and a teacher and office director at Nanyuan Primary School in Jinhua, Zhejiang. He is currently a member of the Jinhua City State-owned Enterprise Supervisor and Chief Financial Officer Management Center.
Yuan Jie: born in November 1958, bachelor's degree, practicing pharmacist. Joined the work in December 1976 and served as political instructor, party branch secretary, and directly affiliated party committee member of the Nanjing Military Region Air Force 86988 Force Command Company. Deputy manager of the material company, Jinhua Qiaozhi Leather & Plastic Co., Ltd. served as deputy secretary of the party branch, chairman of the labor union, and general manager of Jianfeng Pharmacy. He is currently the secretary of the general party branch of Jinhua pharmaceutical co., ltd. and a supervisor of the company.
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page